Cannabis Bioscience International Holdings (CBIH) Profit After Tax (2022 - 2026)
Cannabis Bioscience International Holdings' (CBIH) quarterly Profit After Tax came in at -$103933.0 in Q1 2026, up 42.66% year-on-year from -$72856.0 in Q1 2025, and up 11.14% quarter-over-quarter from -$116966.0 in Q4 2025.
Cannabis Bioscience International Holdings (CBIH) Profit After Tax (2022 - 2026) Analysis & Trends
Cannabis Bioscience International Holdings has disclosed Profit After Tax across 5 years of filings, most recently posting -$103933.0 for Q1 2026.
- Profit After Tax for Q1 2026 came in at -$103933.0, up 42.66% year-over-year; the trailing twelve-month figure through Feb 2026 was -$515288.0 (down 8.94% YoY), and the FY2025 annual result was -$548820.0, up 15.74% from the prior year.
- Profit After Tax came in at -$103933.0 for Q1 2026 at Cannabis Bioscience International Holdings, up from -$116966.0 in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of -$76305.0 in Q3 2024 to a low of -$324655.0 in Q1 2023.
- The 5-year median for Profit After Tax is -$158589.0 (2024), against an average of -$166018.2.
- Across the five-year window, Profit After Tax surged 58.03% in 2024 and slumped 55.77% in 2025, its largest moves.
- Cannabis Bioscience International Holdings' Profit After Tax stood at -$219886.0 in 2022, then soared by 43.41% to -$124426.0 in 2023, then surged by 36.08% to -$79528.0 in 2024, then plunged by 47.08% to -$116966.0 in 2025, then gained by 11.14% to -$103933.0 in 2026.
- The last three Profit After Tax figures came in at -$103933.0 (Q1 2026), -$116966.0 (Q4 2025), and -$82645.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | 369.00 Mn |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | 601.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 274.90 Mn |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | 197.90 Mn |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | 11.81 Mn |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | 57.00 Mn |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | 16.20 Mn |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | 118.42 Mn |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | 52.86 Mn |
| 10 | Cannabis Bioscience International Holdings | - | - | 8,160.00 | -103,933.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -103,933.00 |
| Nov 30, 2025 | -116,966.00 |
| Aug 31, 2025 | -82,645.00 |
| May 31, 2025 | -211,744.00 |
| Feb 28, 2025 | -181,243.00 |
| Nov 30, 2024 | -79,528.00 |
| Aug 31, 2024 | -76,305.00 |
| May 31, 2024 | -135,935.00 |
| Feb 29, 2024 | -209,192.00 |
| Nov 30, 2023 | -124,426.00 |
| Aug 31, 2023 | -181,792.00 |
| May 31, 2023 | -276,005.00 |
| Feb 28, 2023 | -324,655.00 |
| Nov 30, 2022 | -219,886.00 |